BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 34058168)

  • 21. Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure.
    Eoh KJ; Lee YJ; Kim HS; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Surg Oncol; 2018 Sep; 27(3):514-519. PubMed ID: 30217312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Prospective Cohort Study Comparing Colorimetric and Fluorescent Imaging for Sentinel Lymph Node Mapping in Endometrial Cancer.
    Holloway RW; Ahmad S; Kendrick JE; Bigsby GE; Brudie LA; Ghurani GB; Stavitzski NM; Gise JL; Ingersoll SB; Pepe JW
    Ann Surg Oncol; 2017 Jul; 24(7):1972-1979. PubMed ID: 28265777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective validation of the laparoscopic ICG SLN mapping in patients with grade 3 endometrial cancer.
    Papadia A; Gasparri ML; Radan AP; Stämpfli CAL; Rau TT; Mueller MD
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1385-1393. PubMed ID: 29691646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Extraordinary Location of Sentinel Lymph Nodes in a Patient with Endometrial Cancer.
    Comba C; Aslan E; Vatankulu B; Tatar Z; Demir AA; Demir O
    J Minim Invasive Gynecol; 2023 Aug; 30(8):613-614. PubMed ID: 37137423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma.
    Mueller JJ; Pedra Nobre S; Braxton K; Alektiar KM; Leitao MM; Aghajanian C; Ellenson LH; Abu-Rustum NR
    Gynecol Oncol; 2020 Jun; 157(3):619-623. PubMed ID: 32247604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer.
    Baiocchi G; Mantoan H; Kumagai LY; Gonçalves BT; Badiglian-Filho L; de Oliveira Menezes AN; Faloppa CC; De Brot L; da Costa AABA
    Ann Surg Oncol; 2017 Dec; 24(13):3981-3987. PubMed ID: 29058141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective validation of an intraoperative algorithm to guide surgical staging in early endometrial cancer.
    Lefringhouse JR; Elder JW; Baldwin LA; Miller RW; DeSimone CP; van Nagell JR; Samoyoa LM; West DS; Dressler EV; Liu M; Ueland FR
    Gynecol Oncol; 2017 Apr; 145(1):50-54. PubMed ID: 28190648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
    Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tailoring postoperative management through sentinel lymph node biopsy in low- and intermediate-risk endometrial cancer - the SENTRY clinical trial.
    Sorokin P; Novozhilov M; Utkin D; Abduragimova Z; Dudina I; Nikiforchin A; Kulikova S
    Klin Onkol; 2024; 38(2):126-133. PubMed ID: 38697821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a survival advantage in diagnosing endometrial cancer in asymptomatic postmenopausal patients? An Israeli Gynecology Oncology Group study.
    Gemer O; Segev Y; Helpman L; Hag-Yahia N; Eitan R; Raban O; Vaknin Z; Leytes S; Ben Arie A; Amit A; Levy T; Namazov A; Volodarsky M; Ben Shachar I; Atlas I; Bruchim I; Lavie O
    Am J Obstet Gynecol; 2018 Aug; 219(2):181.e1-181.e6. PubMed ID: 29792852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis.
    How JA; O'Farrell P; Amajoud Z; Lau S; Salvador S; How E; Gotlieb WH
    Minerva Ginecol; 2018 Apr; 70(2):194-214. PubMed ID: 29185673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometrial cancer-how many patients could benefit from sentinel lymph node dissection?
    Brugger S; Hamann M; Mosner M; Beer M; Braun M; Pölcher M
    World J Surg Oncol; 2018 May; 16(1):95. PubMed ID: 29773071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).
    Ballester M; Dubernard G; Lécuru F; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Daraï E
    Lancet Oncol; 2011 May; 12(5):469-76. PubMed ID: 21489874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective evaluation of the sentinel node mapping algorithm in endometrial cancer and correlation of its performance against endometrial cancer risk subtypes.
    Rajanbabu A; Agarwal R
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():77-80. PubMed ID: 29554604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety and feasibility of minimally invasive sentinel lymph node staging using indocyanine green in the management of endometrial cancer.
    Mendivil AA; Abaid LN; Brown JV; Mori KM; Beck TL; Epstein HD; Micha JP; Goldstein BH
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():29-32. PubMed ID: 29529474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.
    Cabrera S; Bebia V; Franco-Camps S; Forcada C; Villasboas-Rosciolesi D; Navales I; Pérez-Benavente A; Gil-Moreno A
    Int J Gynecol Cancer; 2020 Mar; 30(3):311-317. PubMed ID: 31992599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter noninferior randomized controlled study of sentinel lymph node biopsy alone versus sentinel lymph node biopsy plus lymphadenectomy for patients with stage I endometrial cancer, INSEC trial concept.
    Guo Y; Sun L; Chen X; Wen Q; Shao Z; Tang X; Shi X; Wang J; Zhang Y; Zhu T
    BMC Cancer; 2023 Dec; 23(1):1184. PubMed ID: 38041023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel node identification and intraoperative lymphatic mapping. First results of a pilot study in patients with endometrial cancer.
    Fersis N; Gruber I; Relakis K; Friedrich M; Becker S; Wallwiener D; Wagner U
    Eur J Gynaecol Oncol; 2004; 25(3):339-42. PubMed ID: 15171314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
    Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
    Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.